Open-Label Extension Study of BBP-418 (Ribitol) for LGMD2I/R9

Clinical trial NCT07678775 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07678775
Sponsor: ML Bio Solutions, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I)

Start date: 2026-06-05
Primary completion: 2030-10-01
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.